Eur Rev Med Pharmacol Sci 2021; 25 (2): 580-582
DOI: 10.26355/eurrev_202101_24614

Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients

Y. Singh, G. Gupta, K. Anand, N. Kumar Jha, L. Thangavelu, D. Kumar Chellappan, K. Dua

Mahatma Gandhi College of Pharmaceutical Sciences, Sitapura, Jaipur, India. gauravpharma25@gmail.com

Free PDF Download

To cite this article

Y. Singh, G. Gupta, K. Anand, N. Kumar Jha, L. Thangavelu, D. Kumar Chellappan, K. Dua
Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 2
Pages: 580-582
DOI: 10.26355/eurrev_202101_24614

Keywords Related articles:

  1. Metformin plus proton pump inhibitors therapy: the cobalamin deficiency challenge
  2. Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice
  3. Improvement of serum adiponectin and leptin concentrations: effects of a low-calorie or isocaloric diet combined with metformin or orlistat – a prospective randomized open-label trial
  4. Same pandemic but different studies: an exploration of COVID-19 research at the early stage
  5. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue – A short report